Stock listing
Tradegate:CT9 Cardiol Therapeutics Inc. Aktie
German listing (Tradegate) of Cardiol Therapeutics Inc. · home listing TSX:CRDL
Follow Cardiol Therapeutics Inc. into a list and get an email when it puts out news.
Home listing price · TSX:CRDL
$1.50 CAD +0.03 (+2.0%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSX:CRDL
- Day range
- $1.46 – $1.50 CADNov 3, 2026
- Volume
- 68,331 sharesNov 3, 2026
- Market cap
- $182.3M CADAt the close on Nov 3, 2026 · price × 121.5M shares outstanding
- 52-week range
- $1.23 – $3.23 CADLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $588,969 CADMedian day 211,934 shares · last 3 months, Aug 4, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:CRDL · Home | $1.50 CAD | +0.03 (+2.0%) | 68,331 | $1.47 | $1.50 | $1.46 | $1.47 | Close on Nov 3, 2026 |
| NASDAQ:CRDL | $1.14 USD | +0.02 (+1.8%) | 312,239 | $1.12 | $1.16 | $1.12 | $1.12 | Close on Oct 27, 2026 |
| Frankfurt:CT9 | €0.988 EUR | +0.016 (+1.6%) | — | €0.988 | €0.988 | €0.988 | €0.972 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 3, 2026 · TSX:CRDL · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.50 | +0.03 | +2.0% | $1.47 | $1.50 | $1.46 | 68,331 | |
| $1.47 | -0.15 | -9.3% | $1.57 | $1.57 | $1.45 | 112,524 | |
| $1.62 | -0.04 | -2.4% | $1.65 | $1.65 | $1.545 | 117,562 | |
| $1.66 | -0.02 | -1.2% | $1.68 | $1.71 | $1.63 | 145,461 | |
| $1.68 | +0.06 | +3.7% | $1.64 | $1.68 | $1.59 | 102,227 | |
| $1.62 | +0.02 | +1.3% | $1.59 | $1.63 | $1.59 | 81,606 | |
| $1.60 | +0.01 | +0.6% | $1.60 | $1.61 | $1.57 | 63,535 | |
| $1.59 | -0.05 | -3.0% | $1.65 | $1.65 | $1.55 | 134,973 | |
| $1.64 | -0.02 | -1.2% | $1.66 | $1.67 | $1.61 | 133,600 | |
| $1.66 | +0.03 | +1.8% | $1.63 | $1.66 | $1.62 | 143,300 | |
| $1.63 | +0.06 | +3.8% | $1.57 | $1.64 | $1.54 | 134,800 | |
| $1.57 | -0.01 | -0.6% | $1.57 | $1.58 | $1.53 | 97,800 | |
| $1.58 | -0.02 | -1.3% | $1.62 | $1.62 | $1.54 | 144,200 | |
| $1.60 | 0.00 | 0.0% | $1.64 | $1.65 | $1.60 | 279,400 | |
| $1.60 | -0.11 | -6.4% | $1.70 | $1.70 | $1.60 | 158,400 | |
| $1.71 | -0.07 | -3.9% | $1.75 | $1.765 | $1.68 | 217,600 | |
| $1.78 | -0.07 | -3.8% | $1.87 | $1.88 | $1.77 | 179,600 | |
| $1.85 | 0.00 | 0.0% | $1.81 | $1.90 | $1.81 | 210,900 | |
| $1.85 | -0.03 | -1.6% | $1.86 | $1.95 | $1.83 | 358,100 | |
| $1.88 | -0.05 | -2.6% | $1.92 | $1.96 | $1.83 | 340,900 | |
| $1.93 | -0.10 | -4.9% | $2.03 | $2.04 | $1.83 | 500,600 | |
| $2.03 | -0.20 | -9.0% | $2.28 | $2.33 | $2.00 | 600,600 | |
| $2.23 | -0.14 | -5.9% | $2.36 | $2.36 | $2.18 | 193,600 | |
| $2.37 | -0.04 | -1.7% | $2.42 | $2.42 | $2.33 | 76,400 | |
| $2.41 | +0.02 | +0.8% | $2.38 | $2.42 | $2.375 | 118,200 | |
| $2.39 | -0.04 | -1.6% | $2.40 | $2.41 | $2.35 | 113,100 | |
| $2.43 | 0.00 | 0.0% | $2.44 | $2.45 | $2.365 | 125,200 | |
| $2.43 | -0.06 | -2.4% | $2.41 | $2.46 | $2.355 | 241,300 | |
| $2.49 | -0.18 | -6.7% | $2.66 | $2.705 | $2.42 | 396,800 | |
| $2.67 | +0.03 | +1.1% | $2.64 | $2.76 | $2.61 | 238,000 | |
| $2.64 | +0.03 | +1.1% | $2.66 | $2.70 | $2.56 | 202,800 | |
| $2.61 | -0.03 | -1.1% | $2.63 | $2.775 | $2.57 | 880,000 | |
| $2.64 | +0.02 | +0.8% | $2.64 | $2.675 | $2.60 | 221,700 | |
| $2.62 | +0.04 | +1.6% | $2.58 | $2.64 | $2.52 | 302,800 | |
| $2.58 | -0.19 | -6.9% | $2.75 | $2.75 | $2.545 | 166,800 | |
| $2.77 | +0.02 | +0.7% | $2.71 | $2.83 | $2.71 | 172,400 | |
| $2.75 | -0.02 | -0.7% | $2.82 | $2.87 | $2.70 | 255,700 | |
| $2.77 | -0.39 | -12.3% | $3.13 | $3.13 | $2.73 | 388,700 | |
| $3.16 | +0.10 | +3.3% | $3.04 | $3.23 | $3.04 | 440,200 | |
| $3.06 | +0.01 | +0.3% | $3.04 | $3.085 | $2.99 | 391,100 | |
| $3.05 | +0.07 | +2.3% | $2.98 | $3.07 | $2.93 | 185,500 | |
| $2.98 | -0.03 | -1.0% | $2.97 | $3.03 | $2.88 | 307,000 | |
| $3.01 | -0.02 | -0.7% | $3.00 | $3.10 | $2.90 | 342,400 | |
| $3.03 | +0.28 | +10.2% | $2.73 | $3.03 | $2.71 | 342,900 | |
| $2.75 | +0.05 | +1.9% | $2.70 | $2.75 | $2.62 | 186,400 | |
| $2.70 | -0.17 | -5.9% | $2.87 | $2.90 | $2.65 | 315,700 | |
| $2.87 | -0.10 | -3.4% | $2.92 | $3.00 | $2.83 | 317,900 | |
| $2.97 | +0.21 | +7.6% | $2.81 | $3.15 | $2.81 | 627,600 | |
| $2.76 | +0.18 | +7.0% | $2.59 | $2.79 | $2.56 | 275,862 | |
| $2.58 | 0.00 | 0.0% | $2.56 | $2.59 | $2.44 | 212,968 | |
| $2.58 | -0.03 | -1.1% | $2.63 | $2.63 | $2.56 | 146,500 | |
| $2.61 | -0.09 | -3.3% | $2.69 | $2.75 | $2.53 | 338,600 | |
| $2.70 | +0.09 | +3.4% | $2.65 | $2.70 | $2.57 | 293,100 | |
| $2.61 | +0.12 | +4.8% | $2.52 | $2.63 | $2.42 | 218,800 | |
| $2.49 | -0.02 | -0.8% | $2.47 | $2.69 | $2.45 | 351,900 | |
| $2.51 | +0.09 | +3.7% | $2.35 | $2.53 | $2.29 | 408,000 | |
| $2.42 | +0.30 | +14.2% | $2.12 | $2.45 | $2.09 | 360,800 | |
| $2.12 | +0.01 | +0.5% | $2.10 | $2.12 | $1.995 | 236,800 | |
| $2.11 | +0.05 | +2.4% | $2.07 | $2.12 | $2.015 | 151,800 | |
| $2.06 | +0.07 | +3.5% | $1.99 | $2.09 | $1.93 | 264,800 | |
| $1.99 | +0.06 | +3.1% | $1.91 | $1.99 | $1.89 | 128,000 | |
| $1.93 | +0.03 | +1.6% | $1.88 | $1.94 | $1.855 | 130,600 | |
| $1.90 | -0.02 | -1.0% | $1.91 | $1.92 | $1.85 | 117,300 | |
| $1.92 | +0.16 | +9.1% | $1.80 | $1.92 | $1.80 | 197,300 |
- Ticker
- Tradegate:CT9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Nov 3, 2026
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 43 slides
Latest news
Ellis Martin Report: Cardiol Therapeutics (CRDL) CEO David Elsley Discusses Phase III MAVERIC and What Comes Next for CardiolRx
Oct 8, 2026
Closed $1.85 (0.0%) on Oct 8, 2026
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx(TM)'s Efficacy
Sep 23, 2026
Closed $2.49 (-6.7%) on Sep 23, 2026
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
Sep 16, 2026
Closed $2.62 (+1.6%) on Sep 16, 2026
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission
Sep 10, 2026
Closed $2.75 (-0.7%) on Sep 11, 2026
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 9, 2026
Closed $3.16 (+3.3%) on Sep 9, 2026
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
Aug 5, 2026
Closed $1.90 (-1.0%) on Aug 5, 2026
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association
Jul 14, 2026
Closed $1.63 (+8.7%) on Jul 14, 2026
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit
Jul 9, 2026
Closed $1.46 (+1.4%) on Jul 9, 2026
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
Jun 25, 2026
Closed $1.51 (+1.3%) on Jun 25, 2026
Financings
At-the-market programme of common shares
Nov 3, 2026
Announced: up to US$75M · Jefferies LLC
Dealers: Jefferies LLC (lead)
Use of proceeds: Develop CardiolRx for recurrent pericarditis (incl. possible NDA), clinical development of CRD-38, G&A, working capital and other expenses
Decks
Investor Presentation (October 2026)
Investor deck · 43 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 43 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 43 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 43 slides · July 2026
Cardiol Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 159 in all · newest Nov 3, 2026 · oldest 2018
- Decks
- 33 decks · latest October 2026
Where Cardiol Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:CRDL · Home listing | TSX | Canada | CAD |
| NASDAQ:CRDL | NASDAQ | United States | USD |
| Cboe Canada:CRDL | Cboe Canada | Canada | CAD |
| LS Exchange:A2PA9E | LS Exchange | Germany | EUR |
| Tradegate:CT9 · This page | Tradegate | Germany | EUR |
| Lang & Schwarz:A2PA9E | Lang & Schwarz | Germany | EUR |
| gettex:CT9 | gettex | Germany | EUR |
| BOATS:CRDL | BOATS | United States | USD |
| Hamburg:CT9 | Hamburg | Germany | EUR |
| Munich:CT9 | Munich | Germany | EUR |
| Dusseldorf:CT9 | Dusseldorf | Germany | EUR |
| Frankfurt:CT9 | Frankfurt | Germany | EUR |
| Stuttgart:CT9 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Cardiol Therapeutics Inc.